Ignite Creation Date:
2024-05-06 @ 2:13 AM
Last Modification Date:
2024-10-26 @ 11:15 AM
Study NCT ID:
NCT01994577
Status:
COMPLETED
Last Update Posted:
2018-07-26
First Post:
2013-11-19
Brief Title:
Optimum Troponin Cutoffs for ACS in the ED
Sponsor:
Organization:
McMaster University
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
In accordance with the Third Universal Definition of MI and recommendations by both Canadian and international expert groups we will collect and measure blood for cTnI and hs-cTn measurements at ED presentation and 3 hours later for patients who currently would only undergo a single cTn measurement and 6 hours later if serial cTn measurements are required This does not preclude cTn measurements for clinical purposes at any additional times of choosing by the EP
Enrollment Count:
100
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 23544 |
Who Masked List: